Veronique Davoust, DPharm Pfizer, Inc.

Veronique Davoust, DPharm

Veronique Davoust, DPharm Pfizer, Inc.

Véronique Davoust has over 20 years’ experience in the pharmaceutical industry, both in regulatory affairs and manufacturing, for Pfizer Inc. In her current position,she is responsible for the monitoring and analysis of European emerging regulations and guidelines, especially focusing on Good Manufacturing Practices and registration of the quality section of marketing authorization dossiers throughout the product life cycle, as well as on global topics such as serialization. Véronique ensures the communication and implementation of the guidelines and regulations within the firm, and the coordination of responses to proposed regulatory documents to the competent authorities.

Véronique has been an active member of the PDA for more than 15 years. She was a member of the Board of Directors from 2007 to 2010, and co-chaired the PDA Paradigm Change in Manufacturing Operations (PCMO) project since its creation in 2008. She contributed to the PDA Technical Report No 54: Implementation of Quality Risk Management for Commercial and Biotech Manufacturing Operations.

Véronique recently joined the PDA Regulatory Affairs and Quality Advisory Board and is a frequent lecturer at PDA conferences and meetings.

Véronique is a pharmacist and earned a Doctorate in Pharmacy from the University of Rouen in Normandie, France.